Miriam Redegalli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Journal: Frontiers in immunology

Published: April 26, 2023

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 22, 2023

In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.

In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.

Journal: Cancer cell

Published: February 17, 2023

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?

Journal: Cells

Published: February 09, 2023

Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors.

Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors.

Journal: Endocrine pathology

Published: December 09, 2022

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

Journal: Cancers

Published: November 16, 2022

Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system.

Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system.

Journal: Virchows Archiv : an international journal of pathology

Published: September 20, 2022

Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.

Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 04, 2022

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.

Journal: Gut

Published: June 14, 2022

ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.

ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.

Journal: Annals of surgical oncology

Published: February 02, 2022

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC).

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC).

Journal: Annals of surgical oncology

Published: September 13, 2021

RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features.

RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features.

Journal: Cells

Published: October 30, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026